Sierra Leone
Médecins Sans Frontières (MSF) is working to reduce Sierra Leone’s maternal and child mortality rates, which are among the highest globally. We also run a project improving access to tuberculosis (TB) treatment.
Our activities in 2024 —
outpatient consultations
malaria cases treated
births assisted
people started on treatment for TB
In Kenema district, Eastern province, pregnant women, lactating mothers, and children under the age of five receive lifesaving medical care in the 164-bed mother and child hospital built by MSF. In addition, we run mobile clinics to serve communities living in remote villages where no healthcare is available.
Our teams provide rapid malaria testing and treatment, vaccinations for children under five years old, family planning, antenatal care, and referrals to specialist facilities. In 2024, we also supported six general healthcare facilities in the district, by donating medical supplies, renovating buildings, and training Ministry of Health medical staff.
In Tonkolili district, Northern province, our teams continued to support 12 healthcare facilities by supplying medicines, completing rehabilitation work, providing water and sanitation services, and training medical staff. With our support, we aim to reduce maternal and child deaths in Mile 91, Magburaka town, and the surrounding villages. In 2024, we drilled seven boreholes in the district to ensure that people have safe drinking water. In Magburaka government hospital, we continue to offer specialist care for pregnant women, lactating mothers, and children under the age of five, and support the referral of patients in need of more advanced care from a general healthcare facility to the hospital.
In Bombali district, also in Northern province, MSF is working to improve access to diagnosis and treatment for both drug-sensitive and drugresistant TB for adults and children. People who are at high risk of contracting TB are provided preventive therapy through the country’s National Leprosy and Tuberculosis Control Programme, of which MSF is supporting the rollout.